LON:AMS

Advanced Medical Solutions Group (AMS) Price Target & Analyst Ratings

GBX 230

-8.00 (-3.36%)

(As of 05/26/2023 04:35 PM ET)

Compare

Today's Range: 221.50
▼
242.57
50-Day Range: 219.50
▼
253
52-Week Range: 215.50
▼
318.50

Volume: 137,483 shs
Average Volume: 302,376 shs
Market Capitalization: £498.96 million

P/E Ratio: 2,555.56
Dividend Yield: 0.87%
Price Target: GBX 303

Profile Analyst Ratings Chart Competitors Dividend Insider Trades Headlines

Advanced Medical Solutions Group Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 2 Analyst Ratings

Consensus Analyst Price Target

GBX 303

High Prediction	GBX 310
Average Prediction	GBX 303
Low Prediction	GBX 296

Type	Current 5/29/22 to 5/29/23	1 Month Ago 4/29/22 to 4/29/23	3 Months Ago 2/28/22 to 2/28/23	1 Year Ago 5/29/21 to 5/29/22
Consensus Rating	Moderate Buy	Moderate Buy	N/A	N/A
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A	N/A
Buy	1 Buy rating(s)	1 Buy rating(s)	N/A	N/A
Hold	1 Hold rating(s)	1 Hold rating(s)	N/A	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	N/A	N/A
Consensus Price Target	GBX 303	GBX 303	N/A	N/A

Get Advanced Medical Solutions Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for AMS and its competitors with MarketBeat's FREE daily newsletter.

AMS Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AMS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Advanced Medical Solutions Group Stock vs. The Competition

Type	Advanced Medical Solutions Group	Medical Companies
Consensus Rating Score	2.50	2.66
Consensus Rating	Moderate Buy	Buy
News Sentiment Rating	Very Positive News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
3/15/2023	Liberum Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Hold	GBX 296	+20.57%
3/15/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	GBX 310	+27.31%

(Data available from 5/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

AMS Price Target - Frequently Asked Questions

What is Advanced Medical Solutions Group's consensus rating and price target?: According to the issued ratings of 2 analysts in the last year, the consensus rating for Advanced Medical Solutions Group stock is Moderate Buy based on the current 1 hold rating and 1 buy rating for AMS. The average twelve-month price prediction for Advanced Medical Solutions Group is GBX 303 with a high price target of GBX 310 and a low price target of GBX 296. Learn more on AMS's analyst rating history.
Do Wall Street analysts like Advanced Medical Solutions Group more than its competitors?: Analysts like Advanced Medical Solutions Group less than other Medical companies. The consensus rating for Advanced Medical Solutions Group is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how AMS compares to other companies.
Is Advanced Medical Solutions Group being downgraded by Wall Street analysts?: Over the previous 90 days, Advanced Medical Solutions Group's stock had 1 downgrade by analysts.

Does Advanced Medical Solutions Group's stock price have much upside?: According to analysts, Advanced Medical Solutions Group's stock has a predicted upside of 23.93% based on their 12-month price targets.
What analysts cover Advanced Medical Solutions Group?: Advanced Medical Solutions Group has been rated by Berenberg Bank, and Liberum Capital in the past 90 days.

Stock Ratings Reports and Tools

This page (LON:AMS) was last updated on 5/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial